Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oropharyngeal Neoplasms | 2 | 2014 | 260 | 0.640 |
Why?
|
| Papillomavirus Infections | 2 | 2014 | 394 | 0.580 |
Why?
|
| Alcohol Drinking | 2 | 2014 | 341 | 0.430 |
Why?
|
| Human papillomavirus 16 | 1 | 2013 | 97 | 0.370 |
Why?
|
| Smoking | 2 | 2014 | 932 | 0.360 |
Why?
|
| Precancerous Conditions | 1 | 2014 | 281 | 0.340 |
Why?
|
| Mentoring | 2 | 2022 | 85 | 0.320 |
Why?
|
| Delivery of Health Care | 3 | 2025 | 689 | 0.290 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 2065 | 0.280 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 750 | 0.260 |
Why?
|
| Telemedicine | 2 | 2025 | 526 | 0.260 |
Why?
|
| Mental Disorders | 2 | 2025 | 910 | 0.230 |
Why?
|
| Qualitative Research | 3 | 2025 | 730 | 0.230 |
Why?
|
| Occupational Exposure | 1 | 2025 | 135 | 0.210 |
Why?
|
| Women | 1 | 2024 | 17 | 0.200 |
Why?
|
| Women's Health | 1 | 2025 | 134 | 0.200 |
Why?
|
| Veterans | 2 | 2025 | 1763 | 0.200 |
Why?
|
| Veterans Health | 1 | 2025 | 170 | 0.200 |
Why?
|
| Military Personnel | 1 | 2025 | 219 | 0.190 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2023 | 38 | 0.190 |
Why?
|
| Patient Care Team | 2 | 2024 | 562 | 0.190 |
Why?
|
| Neck Injuries | 1 | 2022 | 22 | 0.190 |
Why?
|
| Rib Fractures | 1 | 2022 | 27 | 0.190 |
Why?
|
| Environmental Exposure | 1 | 2025 | 298 | 0.190 |
Why?
|
| Analgesia, Epidural | 1 | 2022 | 30 | 0.180 |
Why?
|
| Delphi Technique | 1 | 2024 | 283 | 0.180 |
Why?
|
| Thoracic Injuries | 1 | 2022 | 82 | 0.180 |
Why?
|
| Text Messaging | 1 | 2022 | 42 | 0.180 |
Why?
|
| Acceptance and Commitment Therapy | 1 | 2023 | 44 | 0.180 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2024 | 222 | 0.180 |
Why?
|
| Intensive Care Units | 1 | 2025 | 526 | 0.170 |
Why?
|
| Wounds and Injuries | 1 | 2025 | 398 | 0.170 |
Why?
|
| Motivational Interviewing | 1 | 2022 | 51 | 0.170 |
Why?
|
| Patient Satisfaction | 1 | 2025 | 464 | 0.170 |
Why?
|
| Family | 1 | 2024 | 589 | 0.160 |
Why?
|
| Patient Discharge | 1 | 2025 | 514 | 0.160 |
Why?
|
| Brain Ischemia | 1 | 2023 | 266 | 0.160 |
Why?
|
| Chronic Pain | 1 | 2023 | 168 | 0.160 |
Why?
|
| Critical Care | 1 | 2025 | 686 | 0.150 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 567 | 0.150 |
Why?
|
| Patient Selection | 1 | 2024 | 729 | 0.150 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 259 | 0.150 |
Why?
|
| Health Literacy | 1 | 2020 | 77 | 0.150 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2023 | 245 | 0.150 |
Why?
|
| Ketamine | 1 | 2022 | 206 | 0.150 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 1129 | 0.140 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 223 | 0.140 |
Why?
|
| Pneumonia | 1 | 2022 | 341 | 0.140 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 420 | 0.140 |
Why?
|
| Humans | 24 | 2025 | 131163 | 0.140 |
Why?
|
| Registries | 1 | 2025 | 1634 | 0.140 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 229 | 0.130 |
Why?
|
| Quality of Life | 2 | 2024 | 2082 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1224 | 0.120 |
Why?
|
| Physicians | 1 | 2023 | 635 | 0.120 |
Why?
|
| Incidence | 2 | 2014 | 3360 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 1419 | 0.110 |
Why?
|
| Genomics | 1 | 2024 | 1621 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2024 | 1586 | 0.110 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 650 | 0.110 |
Why?
|
| Quality Improvement | 1 | 2022 | 722 | 0.110 |
Why?
|
| Hospitalization | 1 | 2024 | 1950 | 0.110 |
Why?
|
| United States | 5 | 2025 | 12072 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1061 | 0.110 |
Why?
|
| Matched-Pair Analysis | 1 | 2014 | 28 | 0.110 |
Why?
|
| Causality | 1 | 2014 | 89 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2014 | 318 | 0.100 |
Why?
|
| Age Distribution | 1 | 2014 | 422 | 0.100 |
Why?
|
| Aged | 5 | 2024 | 21025 | 0.100 |
Why?
|
| Single-Blind Method | 1 | 2013 | 238 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2013 | 426 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1459 | 0.090 |
Why?
|
| Female | 9 | 2025 | 70963 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 631 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2014 | 1626 | 0.080 |
Why?
|
| Adult | 5 | 2022 | 31282 | 0.080 |
Why?
|
| Prognosis | 2 | 2024 | 4886 | 0.080 |
Why?
|
| Comorbidity | 1 | 2014 | 1595 | 0.070 |
Why?
|
| Survival Rate | 1 | 2014 | 2114 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2013 | 1287 | 0.070 |
Why?
|
| Heart Failure | 1 | 2022 | 2332 | 0.070 |
Why?
|
| Risk Factors | 2 | 2014 | 11074 | 0.070 |
Why?
|
| Neoplasms | 1 | 2024 | 3016 | 0.070 |
Why?
|
| Male | 6 | 2025 | 64957 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2024 | 1272 | 0.060 |
Why?
|
| Fetal Monitoring | 1 | 2025 | 59 | 0.050 |
Why?
|
| Telephone | 1 | 2025 | 111 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2024 | 99 | 0.050 |
Why?
|
| Middle Aged | 2 | 2014 | 28601 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6797 | 0.050 |
Why?
|
| Perinatology | 1 | 2023 | 32 | 0.050 |
Why?
|
| Gender Identity | 1 | 2024 | 76 | 0.050 |
Why?
|
| Videoconferencing | 1 | 2023 | 21 | 0.050 |
Why?
|
| Resuscitation | 1 | 2025 | 258 | 0.050 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 79 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2023 | 104 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2022 | 129 | 0.040 |
Why?
|
| Medical Oncology | 1 | 2024 | 245 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2023 | 182 | 0.040 |
Why?
|
| Health Services | 1 | 2022 | 69 | 0.040 |
Why?
|
| Pregnancy | 2 | 2025 | 7512 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2025 | 442 | 0.040 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2025 | 729 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2025 | 1240 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2023 | 17753 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2021 | 172 | 0.040 |
Why?
|
| Young Adult | 1 | 2014 | 10103 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 716 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 555 | 0.040 |
Why?
|
| Sleep | 1 | 2023 | 381 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 450 | 0.040 |
Why?
|
| Health Personnel | 1 | 2024 | 541 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1267 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 712 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 1445 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2022 | 413 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2025 | 1295 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 361 | 0.030 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2021 | 259 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2022 | 1246 | 0.030 |
Why?
|
| Length of Stay | 1 | 2022 | 1421 | 0.030 |
Why?
|
| Adolescent | 1 | 2014 | 20987 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2022 | 775 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 1336 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 4066 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6459 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 6196 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8635 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12936 | 0.020 |
Why?
|